Alpha Teknova (TKNO) Stock Forecast: StockMap's 2-Week Call
TKNO stock forecast: StockMap's model leans Outperform on Alpha Teknova for the two weeks after the Nov 19 close, toward TKNO doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 1 of 3 two-week windows on TKNO since Oct 8; by chance, a call on the same dates was right 61% of the time.
Alpha Teknova last closed at $7.81, -0.89% on the session.
Against the IVW growth benchmark the position is +1.44% over the forecast window.
Alpha Teknova's market cap is $491.26M as of November 19, 2026.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 42 (too close to call).
Where TKNO sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 47%.
21 daily calls for TKNO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Alpha Teknova in the 25th percentile on return on equity, where 100 is best.
Alpha Teknova is classified under Health Care / Life Sciences Tools & Services.
StockMap tracks Alpha Teknova as the 36th largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 23 Neutral, 16 Moderate Outperform and 3 Moderate Underperform.
On that composite Alpha Teknova ranks 2nd of 42 in the group, against a group median of +0.13.